Ionis Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Thank you very much for attending the Morgan Stanley 18th Annual Global Healthcare Conference. I'm one of the biotech analysts here. My name is David Lebowitz.
Before I get going, let me begin with the requisite disclosures. Please note that this webcast is for Morgan Stanley clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
And with that, I'm happy to have with me in this session from Ionis Pharmaceuticals, CEO, Brett Monia; and CFO, Beth Hougen. Ionis is a leader of RNA medicine, certainly, focusing on antisense.
I guess, Brett, if you could give me a top-level discussion of Ionis.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |